Skip to main content
Premium Trial:

Request an Annual Quote

Senate Clears Hamburg for FDA

NEW YORK (GenomeWeb News) – The US Senate yesterday confirmed Margaret Hamburg, a biothreat expert with experience running a large organization in New York, and with studying pathogens at the National Institutes of Health, to take over as commissioner at the Food and Drug Administration.

Department of Health and Human Services Director Kathleen Sebelius in a statement called Hamburg "an inspiring public health leader with broad experience in infectious disease, bioterrorism, and health policy. "Her expertise and judgment will serve FDA well," Sebelius said.

For six years, Hamburg was commissioner of health for the City of New York, and was assistant director of the National Institute of Allergy and Infectious Diseases. She also was founding VP for the Biological Program at the Nuclear Threat Initiative and was assistant secretary for planning and evaluation for the Department of Health and Human Services.

Hamburg was confirmed by the Senate's Health, Education, Labor, and Pensions committee.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.